Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Melioidosis | 6 | 2017 | 50 | 2.65 | Why? |
| Burkholderia pseudomallei | 5 | 2017 | 35 | 2.51 | Why? |
| Gastrointestinal Microbiome | 8 | 2019 | 1961 | 1.97 | Why? |
| Sepsis | 13 | 2021 | 3517 | 1.88 | Why? |
| Cellulitis | 2 | 2017 | 119 | 1.25 | Why? |
| Typhoid Fever | 2 | 2018 | 139 | 1.24 | Why? |
| Anti-Bacterial Agents | 12 | 2020 | 10083 | 1.11 | Why? |
| Probiotics | 3 | 2018 | 694 | 0.89 | Why? |
| Survivorship | 1 | 2020 | 106 | 0.76 | Why? |
| Rotavirus Vaccines | 2 | 2018 | 203 | 0.74 | Why? |
| Microbiota | 3 | 2018 | 1240 | 0.73 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.73 | Why? |
| Dysbiosis | 3 | 2018 | 685 | 0.69 | Why? |
| Granzymes | 1 | 2017 | 197 | 0.65 | Why? |
| Pneumonia, Bacterial | 3 | 2020 | 843 | 0.65 | Why? |
| Fasciitis, Necrotizing | 1 | 2017 | 56 | 0.65 | Why? |
| Shift Work Schedule | 1 | 2018 | 137 | 0.61 | Why? |
| Endothelium | 2 | 2021 | 460 | 0.60 | Why? |
| Cephalosporins | 1 | 2018 | 250 | 0.59 | Why? |
| Toll-Like Receptor 2 | 1 | 2015 | 198 | 0.56 | Why? |
| Lipopolysaccharides | 2 | 2017 | 848 | 0.55 | Why? |
| Netherlands | 7 | 2021 | 3533 | 0.54 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.53 | Why? |
| Interleukins | 2 | 2021 | 762 | 0.51 | Why? |
| ADAMTS13 Protein | 1 | 2017 | 363 | 0.50 | Why? |
| Fibrinolysis | 1 | 2018 | 521 | 0.50 | Why? |
| Awareness | 1 | 2018 | 529 | 0.49 | Why? |
| Toll-Like Receptor 4 | 1 | 2015 | 390 | 0.48 | Why? |
| Internal Medicine | 1 | 2018 | 557 | 0.45 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.44 | Why? |
| von Willebrand Factor | 1 | 2017 | 668 | 0.43 | Why? |
| Bacterial Infections | 2 | 2020 | 2229 | 0.38 | Why? |
| Community-Acquired Infections | 2 | 2021 | 2328 | 0.38 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.37 | Why? |
| Intensive Care Units | 6 | 2021 | 29594 | 0.37 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.37 | Why? |
| Critical Illness | 5 | 2020 | 17281 | 0.36 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.34 | Why? |
| Salmonella typhi | 2 | 2018 | 98 | 0.33 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.33 | Why? |
| Thrombocytopenia | 2 | 2018 | 2093 | 0.33 | Why? |
| Critical Care | 5 | 2021 | 14081 | 0.33 | Why? |
| Lipopolysaccharide Receptors | 1 | 2008 | 357 | 0.30 | Why? |
| Mice, Inbred C57BL | 5 | 2017 | 5542 | 0.29 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.28 | Why? |
| Diverticulum, Colon | 1 | 2004 | 4 | 0.28 | Why? |
| Sigmoid Diseases | 1 | 2004 | 13 | 0.28 | Why? |
| Colon, Sigmoid | 1 | 2004 | 22 | 0.28 | Why? |
| Multiple Organ Failure | 3 | 2021 | 1724 | 0.26 | Why? |
| Thailand | 2 | 2017 | 1155 | 0.24 | Why? |
| Immunity, Innate | 2 | 2017 | 6570 | 0.23 | Why? |
| Bangladesh | 2 | 2018 | 1620 | 0.23 | Why? |
| HIV-2 | 1 | 2021 | 92 | 0.21 | Why? |
| Biomedical Research | 2 | 2021 | 5270 | 0.21 | Why? |
| Humans | 44 | 2021 | 930598 | 0.20 | Why? |
| Bacterial Typing Techniques | 1 | 2020 | 273 | 0.19 | Why? |
| Prebiotics | 1 | 2018 | 53 | 0.18 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.18 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.18 | Why? |
| Time and Motion Studies | 1 | 2018 | 65 | 0.18 | Why? |
| DNA, Ribosomal Spacer | 1 | 2017 | 49 | 0.17 | Why? |
| Gabon | 1 | 2017 | 81 | 0.17 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.17 | Why? |
| Flagellin | 1 | 2017 | 22 | 0.17 | Why? |
| Prothrombin | 1 | 2018 | 149 | 0.17 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.17 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.17 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.17 | Why? |
| Theranostic Nanomedicine | 1 | 2018 | 143 | 0.17 | Why? |
| Tattooing | 1 | 2017 | 27 | 0.17 | Why? |
| Tetanus Toxoid | 1 | 2018 | 136 | 0.17 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.16 | Why? |
| Mice, Mutant Strains | 1 | 2015 | 42 | 0.16 | Why? |
| Clinical Deterioration | 1 | 2021 | 473 | 0.16 | Why? |
| Erythrocyte Transfusion | 2 | 2017 | 386 | 0.16 | Why? |
| Genes, Bacterial | 1 | 2017 | 207 | 0.15 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.15 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.15 | Why? |
| Endotoxemia | 1 | 2017 | 143 | 0.15 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.15 | Why? |
| Host-Pathogen Interactions | 1 | 2015 | 11041 | 0.15 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.15 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.14 | Why? |
| Bias | 1 | 2020 | 1109 | 0.14 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.14 | Why? |
| Rotavirus | 1 | 2017 | 329 | 0.14 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.13 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.13 | Why? |
| Animals | 8 | 2019 | 78931 | 0.13 | Why? |
| Fecal Microbiota Transplantation | 1 | 2018 | 372 | 0.13 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.13 | Why? |
| Lung | 3 | 2020 | 31049 | 0.13 | Why? |
| Rotavirus Infections | 1 | 2017 | 355 | 0.13 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.13 | Why? |
| Virulence Factors | 1 | 2015 | 338 | 0.12 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.12 | Why? |
| Mice | 4 | 2019 | 21357 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.12 | Why? |
| Male | 17 | 2021 | 367725 | 0.12 | Why? |
| Adult | 12 | 2021 | 244371 | 0.12 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.12 | Why? |
| Female | 18 | 2021 | 380317 | 0.11 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.11 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.11 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.11 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.11 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.11 | Why? |
| Vaccines, DNA | 1 | 2017 | 871 | 0.10 | Why? |
| Search Engine | 1 | 2018 | 628 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Proteins | 1 | 2017 | 921 | 0.10 | Why? |
| Immunoglobulin A | 2 | 2018 | 3567 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Blood Platelets | 1 | 2021 | 1704 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.09 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.09 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.09 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.09 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.09 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
| Feces | 2 | 2018 | 4235 | 0.09 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Phagocytosis | 1 | 2008 | 409 | 0.08 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.08 | Why? |
| Aged | 8 | 2021 | 215776 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.07 | Why? |
| Lymphocyte Count | 1 | 2017 | 4758 | 0.07 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Mice, Knockout | 1 | 2008 | 1815 | 0.06 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Health Status Disparities | 1 | 2020 | 4072 | 0.06 | Why? |
| HEK293 Cells | 1 | 2015 | 8394 | 0.06 | Why? |
| Fluid Therapy | 2 | 2017 | 628 | 0.06 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2018 | 5993 | 0.06 | Why? |
| Chemotaxis | 1 | 2021 | 67 | 0.06 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.06 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.06 | Why? |
| Platelet Membrane Glycoproteins | 1 | 2021 | 42 | 0.06 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Signal Transduction | 1 | 2015 | 7207 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.05 | Why? |
| Weight Loss | 1 | 2004 | 826 | 0.04 | Why? |
| Abdominal Pain | 1 | 2004 | 858 | 0.04 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| Shock, Septic | 2 | 2017 | 1313 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Platelet Activation | 1 | 2021 | 660 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Macrophages | 1 | 2008 | 2784 | 0.04 | Why? |
| Bacterial Vaccines | 1 | 2017 | 139 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.04 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| Kidney | 1 | 2008 | 3648 | 0.03 | Why? |
| Liver | 1 | 2008 | 4007 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2017 | 714 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.03 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Nutritional Support | 1 | 2017 | 447 | 0.03 | Why? |
| Neutrophils | 1 | 2008 | 5476 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.03 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.02 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Pakistan | 1 | 2017 | 2302 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2004 | 7220 | 0.02 | Why? |
| Emergencies | 1 | 2004 | 4095 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Respiration, Artificial | 2 | 2017 | 22116 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |